This scenario prompted us to embark on this in-depth study with the aim of appraising the impact of MEG3 rs941576 SNP as a novel genetic marker of the risk and clinicopathological features of CRC as well as obesity-related CRC. This evidence concerns the gene MEG3 and obesity due to melanocortin 4 receptor deficiency.